Arthur Brothag

At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 70-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what’s possible to ensure every breath is taken to its fullest. We pledge to evolve what’s possible to ensure every breath is taken to its fullest. We accomplish this through our values: Patient Purpose, Customer First, Employee Success, and Corporate Integrity. The company’s origin began in the 1950s with the invention of the first mechanical ventilator and has since brought together well-known brands with proven track records of pioneering and advancing respiratory diagnostics and ventilation. Formed in 2016, the unified Vyaire established the world’s largest consortium of experts and industry leaders solely focused on the breathing continuum for customers and patients across the globe. Our passionate, dedicated global workforce consists of experienced breathing specialists who are inspired and empowered to elevate the quality of each inhale and each exhale. Vyaire acknowledges and celebrates the individual backgrounds, perspectives, and voices of our team members to best serve the diverse needs of patients and healthcare providers. Bring your unique talents, commitment, and career aspirations to our global team of dedicated professionals. Headquartered in suburban Chicago, Vyaire is recognized, trusted and preferred by specialists throughout the respiratory community worldwide.

Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com

Acelity is a global advanced wound care company, offering innovative solutions from the hospital to home that improve the lives of patients in more than 90 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. Our shared values drive our company’s personality, culture and priorities by providing a framework for making decision: Customer First, Integrity, A Will to Win, One Acelity. We are the undisputed leader in negative pressure wound therapy and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with nearly 5,000 employees around the globe. This channel and specific content are intended for a global audience. Patients should consult with their healthcare providers regarding their specific medical conditions, treatments, information on this channel, and risks and benefits of Acelity products. This channel is not a substitute for professional medical advice, diagnosis, or treatment. Not all Acelity products are available in all countries. Acelity is not responsible for, and does not control/endorse materials such as linked 3rd party videos, sites or ads, and makes no representations regarding their accuracy.

At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 70-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what’s possible to ensure every breath is taken to its fullest. We pledge to evolve what’s possible to ensure every breath is taken to its fullest. We accomplish this through our values: Patient Purpose, Customer First, Employee Success, and Corporate Integrity. The company’s origin began in the 1950s with the invention of the first mechanical ventilator and has since brought together well-known brands with proven track records of pioneering and advancing respiratory diagnostics and ventilation. Formed in 2016, the unified Vyaire established the world’s largest consortium of experts and industry leaders solely focused on the breathing continuum for customers and patients across the globe. Our passionate, dedicated global workforce consists of experienced breathing specialists who are inspired and empowered to elevate the quality of each inhale and each exhale. Vyaire acknowledges and celebrates the individual backgrounds, perspectives, and voices of our team members to best serve the diverse needs of patients and healthcare providers. Bring your unique talents, commitment, and career aspirations to our global team of dedicated professionals. Headquartered in suburban Chicago, Vyaire is recognized, trusted and preferred by specialists throughout the respiratory community worldwide.

Neuraxpharm is the leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com

We are one of Europe’s leading suppliers of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies and the general public. We operate laboratory and medical diagnostic imaging facilities in 15 countries: Czech Republic, Denmark, Finland, France, Italy, KSA, Norway, Peru, Portugal, Slovakia, Spain, Sweden, Switzerland, UAE, and the United Kingdom. Our network of facilities provides us with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe.

Apax Partners LLP ("Apax") is a global private equity advisory firm investing in mid-market businesses across the Technology, Services, and Internet/Consumer sectors. Combining the scale of a global firm with the focus of a sector specialist, Apax works with management teams to create long-term value through operational value creation. With more than 50 years of private equity experience in operational value creation, Apax has raised and advised funds with aggregate commitments of approximately $80 billion.